OncoLogics Chosen to Participate in Model Prostate Cancer Program

OncoLogics, Inc. is one of five cancer programs selected to participate in the Association of Community Cancer Centers’ (ACCC’s) Prostate Cancer “Best Practices” Project. As part of this prestigious program, OncoLogics will participate in on-site education involving processes and structures to create model community-based prostate-specific cancer programs used to initiate and grow successful prostate cancer programs throughout the nation.

“The need for education and support for prostate cancer care is clearly unmet in many communities throughout Louisiana and across the nation,” said Dr. Maitland DeLand, CEO of OncoLogics, Inc. “ACCC’s new Prostate Cancer Project is designed to promote successful community-based prostate-specific cancer programs.”

As part of ACCC’s Prostate Cancer “Best Practices” Project, information about the prostate cancer program at OncoLogics, Inc., will be shared with cancer centers across the United States.

Prostate cancer is unique in that there are equally effective, mutually exclusive treatment options. Increasingly, men diagnosed with prostate cancer are seeking out programs that provide disease-specific information regarding treatment options that focus on the unique issues surrounding the disease. However, many men still believe there may be only one option available to them locally, when there may in fact be more than ten treatment options and some open clinical trials, which may be appropriate for their diagnosis. ACCC’s project seeks to provide cancer centers across the country with the success factors necessary to develop an effective, targeted prostate cancer program in their community, so patients understand all the options available to them.

In addition to OncoLogics, Inc., the other four participants in the program include: Florida Hospital Cancer Institute in Orlando; Good Samaritan Hospital, San Jose, Calif.; Saint Joseph’s Hospital in Atlanta, Ga.; and Tallahassee Memorial Hospital, Tallahassee, Fla.

The Prostate Cancer “Best Practices” Project is funded by an educational grant from Sanofi-Aventis U.S. Education is provided in consultation with The Pritchard Group. For information or questions regarding OncoLogics Incorporated, please contact Nichole Forstall, Chief Operating Officer for OncoLogics, at (337) 237-2057.